• Zhong Ji Longevity Science amended terms on Oct. 27, 2026, for its 25% acquisition of Asian Integrated Cell Laboratory.
• The acquisition involves issuance of convertible notes under a specific mandate.
• The vendor and guarantor must repay the acquired stake's share of Zhong Ji No.1 outstanding debt within nine months of completion.
• The previous deadline was June 30, 2026, or six months from completion, whichever was later.
• The amendment cancels the guarantor's option to settle that debt portion by transferring the Consideration Target IP to the target company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261027-12384923), on October 27, 2026, and is solely responsible for the information contained therein.